World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
90
Citations
35450
World Ranking
1064
National Ranking
34

Medicine

D-Index
90
Citations
35450
World Ranking
12080
National Ranking
450

Delia Goletti publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Delia Goletti sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 406 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Delia Goletti D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Delia Goletti sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 90 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Delia Goletti is affiliated with the Istituto Sperimentale Italiano Lazzaro Spallanzani in Italy. Their research contributions focus predominantly on infectious diseases, with a notable emphasis on tuberculosis and COVID-19.

Their primary field of study is Medicine, with a significant portion of work dedicated to subfields such as Infectious Diseases, Epidemiology, Surgery, Immunology, and Neurology.

The main research topics covered by Goletti include:

  • Tuberculosis Research and Epidemiology
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Mycobacterium research and diagnosis
  • Long-Term Effects of COVID-19
  • Infectious Diseases and Tuberculosis
  • Diagnosis and treatment of tuberculosis

Goletti frequently publishes in several journals, with the top venues being:

  • International Journal of Infectious Diseases
  • Frontiers in Immunology
  • The International Journal of Tuberculosis and Lung Disease
  • European Respiratory Journal
  • Journal of Infection

Frequent co-authors in their work include:

  • Fabrizio Palmieri
  • Linda Petrone
  • Emanuele Nicastri
  • Gina Gualano
  • Gilda Cuzzi

Notable recent publications include:

  • "Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact," 2020, Journal of Infection
  • "Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases," 2020, European Respiratory Journal
  • "The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions," 2023, Frontiers in Immunology
  • "Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects," 2021, Pulmonology
  • "Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts," 2020, Pulmonology

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Towards tuberculosis elimination: an action framework for low-incidence countries

    Knut Lönnroth;Giovanni Battista Migliori;Ibrahim Abubakar;Lia D'Ambrosio

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.

    U Mack;G B Migliori;M Sester;H L Rieder

  • Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

    R. Diel;D. Goletti;G. Ferrara;G. Bothamley

  • Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation.

    Delia Goletti;Drew Weissman;Robert W. Jackson;Neil M.H. Graham

  • The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

    I. Solovic;M. Sester;J. J. Gomez-Reino;H. L. Rieder

  • Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact.

    Fabrizio Cantini;Laura Niccoli;Daniela Matarrese;Emanuele Nicastri

  • Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.

    Marina Tadolini;Luigi Ruffo Codecasa;José María García-García;François Xavier Blanc

  • Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine.

    Aurelio Cafaro;Antonella Caputo;Claudio Fracasso;Maria T. Maggiorella

  • Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

    Christoph Lange;Ibrahim Abubakar;Jan Willem C. Alffenaar;Graham Bothamley

  • MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment.

    Anca Dorhoi;Marco Iannaccone;Maura Farinacci;Kellen C. Faé

  • ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells

    Alessandra Romagnoli;Marilena P. Etna;Elena Giacomini;Manuela Pardini

  • Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects

    D Visca;Cwm Ong;S Tiberi;R Centis

  • Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study

    Martina Sester;Frank van Leth;Judith Bruchfeld;Dragos Bumbacea

  • Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.

    Stefanos Bonovas;Silvia Minozzi;Theodore Lytras;Marien González-Lorenzo

  • Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy.

    Stefania Carrara;Donatella Vincenti;Nicola Petrosillo;Massimo Amicosante

  • The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement

    Dragos Bumbacea;Sandra M. Arend;Fusun Eyuboglu;Jay A. Fishman

  • Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts.

    I. Motta;R. Centis;L. D’Ambrosio;J.-M. García-García

Frequent Co-Authors

Enrico Girardi
Enrico Girardi Austrian Academy of Sciences
Giuseppe Ippolito
Giuseppe Ippolito Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Giovanni Sotgiu
Giovanni Sotgiu University of Sassari
Daniela M. Cirillo
Daniela M. Cirillo Vita-Salute San Raffaele University
Christoph Lange
Christoph Lange University of Lübeck
Giovanni Battista Migliori
Giovanni Battista Migliori Queen Mary University of London
Giovanni Delogu
Giovanni Delogu Catholic University of the Sacred Heart
Tom H. M. Ottenhoff
Tom H. M. Ottenhoff Leiden University Medical Center
Barbara Ensoli
Barbara Ensoli Istituto Superiore di Sanità
Gian Maria Fimia
Gian Maria Fimia Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, nursing offers a wide range of opportunities. Many students start by exploring online RN programs for non nurses, which provide a flexible route to becoming a registered nurse without prior healthcare experience.

Accelerated programs are popular for individuals looking to fast-track their careers. If time is a concern, consider searching for accelerated nursing programs near me, designed to help students earn their Bachelor of Science in Nursing (BSN) in a shorter timeframe.

For those aiming to enter the nursing field quickly, exploring the easiest LPN programs to get into can be a practical first step. Licensed Practical Nurse (LPN) programs offer a foundational pathway into patient care with a shorter study period.

Finally, nurses seeking advanced practice roles might want to know which nurse practitioner program is easiest to navigate, helping them achieve higher credentials and specialize within healthcare.

Best Scientists Citing Delia Goletti

Trending Scientists

Recently Published Articles